Pathophysiology and biology of peritoneal carcinomatosis
Open Access
- 1 January 2010
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 2 (1), 12-18
- https://doi.org/10.4251/wjgo.v2.i1.12
Abstract
Peritoneal carcinomatosis represents a devastating form of cancer progression with a very poor prognosis. Its complex pathogenesis is represented by a dynamic process comprising several steps. To the best of our knowledge pathogenesis can be partly explained by 3 major molecular pathways: (1) dissemination from the primary tumor; (2) primary tumor of peritoneum; and (3) independent origins of the primary tumor and peritoneal implants. These are not mutually exclusive and combinations of different mechanisms could occur inside a single case. There are still several aspects which need explanation by future studies. A comprehensive understanding of molecular events involved in peritoneal carcinomatosis is of paramount importance and should be systematically pursued not only to identify novel strategies for the prevention of the condition, but also to obtain therapeutic advances, through the identification of surrogate markers of prognosis and development of future molecular targeted therapies.Keywords
This publication has 50 references indexed in Scilit:
- SV40-Induced Expression of Calretinin Protects Mesothelial Cells from Asbestos Cytotoxicity and May Be a Key Factor Contributing to Mesothelioma PathogenesisThe American Journal of Pathology, 2009
- Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal MesotheliomaClinical Cancer Research, 2008
- Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolitesCancer Science, 2006
- The Usefulness of CDX-2 for Differentiating Primary and Metastatic Ovarian Carcinoma: An Immunohistochemical Study Using a Tissue MicroarrayJournal of Korean Medical Science, 2005
- Immunohistochemical Characterization of Signet-Ring Cell Carcinomas of the Stomach, Breast, and ColonAmerican Journal of Clinical Pathology, 2004
- Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikuninInternational Journal of Cancer, 2003
- MUC2 Is a Molecular Marker for Pseudomyxoma PeritoneiLaboratory Investigation, 2002
- Cloning and chromosome assignment of the human CDX2 geneAnnals of Human Genetics, 1997
- Molecular Genetic Evidence of a Unifocal Origin for Human Serous Ovarian CarcinomasGynecologic Oncology, 1993
- Pseudomyxoma peritonei from metastatic colloid carcinoma of the breastAbdominal Radiology, 1991